Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR/Cas9 therapeutics: progress and prospects
Tianxiang Li, Yanyan Yang, Hongzhao Qi, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 287

Showing 1-25 of 287 citing articles:

Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming Innovation
Jillian Belgrad, Hassan H. Fakih, Anastasia Khvorova
Nucleic Acid Therapeutics (2024) Vol. 34, Iss. 2, pp. 52-72
Closed Access | Times Cited: 31
Principles of CRISPR-Cas9 technology: Advancements in genome editing and emerging trends in drug delivery
Alaa A. A. Aljabali, Mohamed El‐Tanani, Murtaza M. Tambuwala
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105338-105338
Open Access | Times Cited: 30
Mitochondrial Structure and Function in Human Heart Failure
Antentor Hinton, Steven M. Claypool, Kit Neikirk, et al.
Circulation Research (2024) Vol. 135, Iss. 2, pp. 372-396
Open Access | Times Cited: 25
Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives
Farah Rehan, Mingjie Zhang, Jun Fang, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 2073-2073
Open Access | Times Cited: 22
Rapid DNA unwinding accelerates genome editing by engineered CRISPR-Cas9
Amy R. Eggers, Kai Chen, Katarzyna M. Soczek, et al.
Cell (2024) Vol. 187, Iss. 13, pp. 3249-3261.e14
Open Access | Times Cited: 21
Fluorinated Organic Polymers for Cancer Drug Delivery
Jingrui Xin, Xue Lu, Ji-Min Cao, et al.
Advanced Materials (2024) Vol. 36, Iss. 30
Closed Access | Times Cited: 15
Lactate and lactylation in cancer
Jie Chen, Ziyue Huang, Ya Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Enhancing precision in cancer treatment: the role of gene therapy and immune modulation in oncology
Emile M. Youssef, Brandon Fletcher, Dannelle Palmer
Frontiers in Medicine (2025) Vol. 11
Open Access | Times Cited: 3
CRISPR/Cas9: A Powerful Strategy to Improve CAR-T Cell Persistence
Wei Wei, Zhi‐Nan Chen, Ke Wang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12317-12317
Open Access | Times Cited: 36
Application of CRISPR-Cas9 genome editing technology in various fields: A review
Arif Nur Muhammad Ansori, Yulanda Antonius, Raden JK. Susilo, et al.
Narra J (2023) Vol. 3, Iss. 2, pp. e184-e184
Open Access | Times Cited: 36
Stem cell-derived intestinal organoids: a novel modality for IBD
Cheng‐mei Tian, Meifeng Yang, Haoming Xu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 25
CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine
Dilip Kumar Chanchal, Jitendra Singh Chaudhary, Pushpendra Kumar, et al.
Current Gene Therapy (2024) Vol. 24, Iss. 3, pp. 193-207
Closed Access | Times Cited: 10
Advances in RNA Interference for Plant Functional Genomics: Unveiling Traits, Mechanisms, and Future Directions
Divya Chaudhary, A.S. Jeena, Rohit Rohit, et al.
Applied Biochemistry and Biotechnology (2024) Vol. 196, Iss. 9, pp. 5681-5710
Closed Access | Times Cited: 9
Unlocking the Therapeutic Potential of Marine Collagen: A Scientific Exploration for Delaying Skin Aging
M. Azizur Rahman, Rameesha Rehmani, Diana Gabby Pirvu, et al.
Marine Drugs (2024) Vol. 22, Iss. 4, pp. 159-159
Open Access | Times Cited: 8
Tumor Microenvironment‐Responsive Nanocapsule Delivery CRISPR/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma Carcinoma
Lei He, Zhaozhao Li, Danjie Su, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Open Access | Times Cited: 8
A CRISPR-Cas9 system protecting E. coli against acquisition of antibiotic resistance genes
Danna Lee, P. D. Muir, Sara Lundberg, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
CRISPR/Cas9 System as a Promising Therapy in Thalassemia and Sickle Cell Disease: A Systematic Review of Clinical Trials
Rehab Ahmed, Waad Alghamdi, Fahad A. Al‐Harbi, et al.
Molecular Biotechnology (2025)
Closed Access | Times Cited: 1
Robust genome editing activity and the applications of enhanced miniature CRISPR-Cas12f1
Soo-Ji Park, Sungjin Ju, Won Jun Jung, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Progress and challenges in CRISPR/Cas applications in microalgae
Quynh-Giao Tran, Trang Thi Le, Dong‐Yun Choi, et al.
The Journal of Microbiology (2025) Vol. 63, Iss. 3, pp. e2501028-e2501028
Closed Access | Times Cited: 1
Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy
Ankit Kumar Dubey, Ebrahim Mostafavi
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 20
piRNA-823 is a novel potential therapeutic target in aortic dissection
Min Li, Gang Li, Yanyan Yang, et al.
Pharmacological Research (2023) Vol. 196, pp. 106932-106932
Open Access | Times Cited: 18
Protein-based delivery systems for RNA delivery
Haichao Zhu, Hong Luo, Ruilong Chang, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 253-274
Closed Access | Times Cited: 17
Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management
Khaled S. Allemailem, Mohammed A. Alsahli, Ahmad Almatroudi, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 5531-5559
Open Access | Times Cited: 16
Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy
Colleen Foley, Sheridan L. Swan, Melody A. Swartz
The Journal of Immunology (2024) Vol. 212, Iss. 2, pp. 188-198
Closed Access | Times Cited: 7
Therapeutic In Vivo Gene Editing Achieved by a Hypercompact CRISPR‐Cas12f1 System Delivered with All‐in‐One Adeno‐Associated Virus
Tongtong Cui, Bingyu Cai, Yao Tian, et al.
Advanced Science (2024) Vol. 11, Iss. 19
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top